Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion

被引:9
作者
Beanlands, RSB
deKemp, RA
Harmsen, E
Veinot, JP
Hartman, NG
Ruddy, TD
机构
[1] OTTAWA CIVIC HOSP, DIV ANAT PATHOL, OTTAWA, ON K1Y 4E9, CANADA
[2] OTTAWA CIVIC HOSP, DIV NUCL MED, OTTAWA, ON K1Y 4E9, CANADA
关键词
D O I
10.1016/0735-1097(96)00159-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study evaluated technetium-99m (Tc-99m) teboroxime kinetics in postischemic and partially necrotic myocardium with complete and low flow reperfusion using an isolated perfused rat heart model. Background. Technetium-99m teboroxime has been proposed for use in the early diagnosis of reperfusion after thrombolysis on the basis of models of myocardial necrosis with complete reperfusion, Clinically, however, reperfusion is frequently incomplete, resulting in a mixture of necrotic, ischemic and postischemic tissue. Methods. Hearts were classified into five groups: group 1 (n = 8, control); group 2 (n = 7, 30 min of no how with complete reperfusion); group 3 (n = 12, 60 min of no flea to induce partial necrosis, followed by complete reperfusion); group 4 (n = 8, continuous low flow without flow interruption); and group 5 (n = 9, 60 min of no flow with low flow reperfusion), Buffer containing Tc-99m teboroxime was perfused for 15 min, followed by tracer-free buffer for 35 min, to evaluate uptake and clearance, respectively. Results. Uptake slopes for groups 1 to 5 were (mean +/- SD) 3.0 +/- 0.7, 2.6 +/- 0.8, 2.1 +/- 0.5, 0.8 +/- 0.2 and 0.8 +/- 0.3, respectively (p less than or equal to 0.0005 for groups 1, 2 and 3 vs. groups 4 and 5, and p = 0.003 for group 3 vs. groups 1 and 2). Clearance curves from groups 1 to 3 were best fit by a biexponential function (p < 0.001); those from groups 4 and 5 were monoexponential. In groups 1, 2 and 3, the initial clearance rate constants (k(1)) (0.9 +/- 0.5 x 10(-3); 1.0 +/- 0.2 x 10(-3); 1.1 +/- 0.5 x 10(-3) s(-1), respectively) and the monoexponential rate constants (k(mono)) (2.0 +/- 0.3 x 10(-4); 2.2 +/- 0.4 x 10(-4); 2.1 +/- 0.2 x 10(-4) s(-1), respectively) were significantly greater than those in groups 4 and 5 (0.9 +/- 0.5 x 10(-4); 1.2 +/- 0.3 x 10(-4) s(-1), respectively, p less than or equal to 0.005). Conclusions. The uptake and initial clearance kinetics of Tc-99m teboroxime depend mainly on myocardial flow in this model, The presence of partial necrosis and postischemic injury has little effect on the initial clearance but leads to some reduction in uptake at normal flow rates. Evaluation of Tc-99m teboroxime kinetics may permit early noninvasive detection of inadequate reperfusion in acute myocardial infarction.
引用
收藏
页码:487 / 494
页数:8
相关论文
共 28 条
[1]  
ABRAHAM SA, 1995, J NUCL MED, V36, P1062
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]   DIFFERENT TYPES OF MYOCARDIAL NECROSIS IN CORONARY HEART-DISEASE - PATHOPHYSIOLOGIC REVIEW OF THEIR FUNCTIONAL SIGNIFICANCE [J].
BAROLDI, G .
AMERICAN HEART JOURNAL, 1975, 89 (06) :742-752
[4]   THE RELATIONSHIP BETWEEN MYOCARDIAL RETENTION OF TC-99M TEBOROXIME AND MYOCARDIAL BLOOD-FLOW [J].
BEANLANDS, R ;
MUZIK, O ;
NGUYEN, N ;
PETRY, N ;
SCHWAIGER, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (03) :712-719
[5]   ARE THE KINETICS OF TC-99M METHOXYISOBUTYL ISONITRILE AFFECTED BY CELL-METABOLISM AND VIABILITY [J].
BEANLANDS, RSB ;
DAWOOD, F ;
WEN, WH ;
MCLAUGHLIN, PR ;
BUTANY, J ;
DAMATI, G ;
LIU, PP .
CIRCULATION, 1990, 82 (05) :1802-1814
[6]   ALTERATIONS IN FATTY-ACID METABOLISM IN ADRIAMYCIN CARDIOMYOPATHY [J].
BEANLANDS, RSB ;
SHAIKH, NA ;
WEN, WH ;
DAWOOD, F ;
UGNAT, AM ;
MCLAUGHLIN, PR ;
CARERE, R ;
LIU, PP .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (01) :109-119
[7]   FAILURE OF SIMPLE CLINICAL MEASUREMENTS TO PREDICT PERFUSION STATUS AFTER INTRAVENOUS THROMBOLYSIS [J].
CALIFF, RM ;
ONEIL, W ;
STACK, RS ;
ARONSON, L ;
MARK, DB ;
MANTELL, S ;
GEORGE, BS ;
CANDELA, RJ ;
KEREIAKES, DJ ;
ABBOTTSMITH, C ;
TOPOL, EJ .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (05) :658-662
[8]  
CHANG PI, 1992, CIRCULATION, V86, P707
[9]   CELLULAR-RESPONSE OF THE EVOLVING MYOCARDIAL-INFARCTION AFTER THERAPEUTIC CORONARY-ARTERY REPERFUSION [J].
COWAN, MJ ;
REICHENBACH, D ;
TURNER, P ;
THOSTENSON, C .
HUMAN PATHOLOGY, 1991, 22 (02) :154-163
[10]   INTERACTION OF TECHNETIUM 99M-LABELED TEBOROXIME WITH RED-BLOOD-CELLS REDUCES THE COMPOUNDS EXTRACTION AND INCREASES APPARENT CARDIAC WASHOUT [J].
DAHLBERG, ST ;
GILMORE, MP ;
LEPPO, JA .
JOURNAL OF NUCLEAR CARDIOLOGY, 1994, 1 (03) :270-279